InMed Pharmaceuticals Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company’s operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer’s disease.
Frequently asked questions
To buy InMed Pharmaceuticals Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for InMed Pharmaceuticals Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for InMed Pharmaceuticals Inc is INM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
InMed Pharmaceuticals Inc has its primary listing on NASDAQ (Small cap). You can trade InMed Pharmaceuticals Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, InMed Pharmaceuticals Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include InMed Pharmaceuticals Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like InMed Pharmaceuticals Inc.